Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 3,921,000 $ 411,000 [1]
Accounts receivable 177,000 294,000 [1]
Inventories 1,860,000 2,737,000 [1]
Prepaid expenses and other current assets 1,099,000 641,000 [1]
Total current assets 7,057,000 4,083,000 [1]
Property and equipment, net 62,000 93,000 [1]
Notes receivable 323,000 0
Other assets 575,000 647,000 [1]
Total assets 8,017,000 4,823,000 [1]
Current Liabilities:    
Accounts payable 1,689,000 2,320,000 [1]
Accrued liabilities 1,434,000 1,317,000 [1]
Total current liabilities 3,123,000 3,637,000 [1]
Warrant liabilities 19,000 5,460,000 [1]
Other liabilities 580,000 636,000 [1]
Total liabilities 3,722,000 9,733,000 [1]
Commitments and contingencies (Note 8) [1]
Series B Convertible Redeemable Preferred Stock, par value $0.0001; 375,000 shares authorized; 0 and 38,335 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively [1]   247,000
Stockholders' Equity / (Deficit):    
Common stock, par value $0.0001; 300,000,000 shares authorized; 7,767,828 and 222,380 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively 1,000 1,000 [1]
Additional paid-in capital 296,386,000 241,884,000 [1]
Accumulated deficit (292,092,000) (247,042,000) [1]
Total stockholders' equity / (deficit) 4,295,000 (5,157,000) [1]
Total liabilities, convertible preferred stock and stockholders' equity / (deficit) $ 8,017,000 $ 4,823,000 [1]
[1] The condensed consolidated balance sheet as of December 31, 2023 was derived from the audited consolidated balance sheet as of that date.